Skip to content
OpenCapital
Get started

Aspire Biopharma Holdings, Inc. ASBP Q4 2024 Annual earnings

Reported April 7, 2025 · Before market open

Diluted EPS-$0.27

Next report

Date not yet announced

Versus estimates

Revenue

Q1 2026$28.4KQ4 2025$4.3KQ3 2025$1.9K

Diluted EPS

Q1 2026-$20.57Q4 2025-$1.33Q3 2025-$1.60Q2 2025-$0.04Q1 2025-$0.42
Q4 2024-$0.27

Ask the moment Aspire Biopharma Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Aspire Biopharma Holdings, Inc. report Q4 2024 earnings?
Aspire Biopharma Holdings, Inc. (ASBP) reported Q4 2024 earnings on April 7, 2025 before market open.
What were Aspire Biopharma Holdings, Inc.'s Q4 2024 revenue and EPS?
Aspire Biopharma Holdings, Inc. reported diluted EPS of $-0.27 for Q4 2024.
Where can I find Aspire Biopharma Holdings, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-002917) directly on SEC EDGAR. The filing index links above go to sec.gov.